# Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512

> **NCT03146065** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 79 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-06730512
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03146065
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-10
- **Primary completion:** 2018-05-03
- **Final completion:** 2018-05-03
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2018-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03146065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03146065, "Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03146065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*